PH24634A - Chalcone derivatives and composition - Google Patents
Chalcone derivatives and compositionInfo
- Publication number
- PH24634A PH24634A PH36764A PH36764A PH24634A PH 24634 A PH24634 A PH 24634A PH 36764 A PH36764 A PH 36764A PH 36764 A PH36764 A PH 36764A PH 24634 A PH24634 A PH 24634A
- Authority
- PH
- Philippines
- Prior art keywords
- chalcone derivatives
- composition
- inhibit
- reported
- agents
- Prior art date
Links
- 150000001788 chalcone derivatives Chemical class 0.000 title abstract 3
- 102000029749 Microtubule Human genes 0.000 abstract 1
- 108091022875 Microtubule Proteins 0.000 abstract 1
- 102000004243 Tubulin Human genes 0.000 abstract 1
- 108090000704 Tubulin Proteins 0.000 abstract 1
- 239000002255 antigout agent Substances 0.000 abstract 1
- 229960002708 antigout preparations Drugs 0.000 abstract 1
- 239000003080 antimitotic agent Substances 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000004688 microtubule Anatomy 0.000 abstract 1
- 210000003007 myelin sheath Anatomy 0.000 abstract 1
- 238000006116 polymerization reaction Methods 0.000 abstract 1
- 230000000750 progressive effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/45—Monoamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Liquid Crystal Substances (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3621487A | 1987-04-09 | 1987-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH24634A true PH24634A (en) | 1990-08-17 |
Family
ID=21887305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH36764A PH24634A (en) | 1987-04-09 | 1988-04-07 | Chalcone derivatives and composition |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0287901B1 (de) |
| KR (1) | KR880012529A (de) |
| AT (1) | ATE55108T1 (de) |
| AU (1) | AU608821B2 (de) |
| DE (1) | DE3860376D1 (de) |
| ES (1) | ES2016865B3 (de) |
| GR (1) | GR3000689T3 (de) |
| IE (1) | IE60734B1 (de) |
| PH (1) | PH24634A (de) |
| ZA (1) | ZA882388B (de) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54152091A (en) * | 1978-05-22 | 1979-11-29 | Fuji Photo Film Co Ltd | Photopolymerizable composition |
| US4279930A (en) * | 1978-10-10 | 1981-07-21 | The Upjohn Company | Process for treating inflammation |
| NZ192641A (en) * | 1979-01-26 | 1984-10-19 | Hoffmann La Roche | Substituted acetophenones and pharmaceutical compositions |
| CA1168659A (fr) * | 1980-08-06 | 1984-06-05 | Gerard Lang | Derives de dibenzoylmethane quaternaire, leur utilisation comme agent filtrant solaire et composition cosmetique les contenant |
-
1988
- 1988-04-05 ZA ZA882388A patent/ZA882388B/xx unknown
- 1988-04-05 AU AU14165/88A patent/AU608821B2/en not_active Ceased
- 1988-04-07 ES ES88105541T patent/ES2016865B3/es not_active Expired - Lifetime
- 1988-04-07 AT AT88105541T patent/ATE55108T1/de not_active IP Right Cessation
- 1988-04-07 EP EP88105541A patent/EP0287901B1/de not_active Expired - Lifetime
- 1988-04-07 DE DE8888105541T patent/DE3860376D1/de not_active Expired - Fee Related
- 1988-04-07 PH PH36764A patent/PH24634A/en unknown
- 1988-04-08 IE IE107688A patent/IE60734B1/en not_active IP Right Cessation
- 1988-04-08 KR KR1019880003945A patent/KR880012529A/ko not_active Withdrawn
-
1990
- 1990-08-02 GR GR90400536T patent/GR3000689T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE881076L (en) | 1988-10-09 |
| ZA882388B (en) | 1988-09-22 |
| KR880012529A (ko) | 1988-11-28 |
| AU1416588A (en) | 1988-10-13 |
| EP0287901B1 (de) | 1990-08-01 |
| DE3860376D1 (de) | 1990-09-06 |
| GR3000689T3 (en) | 1991-09-27 |
| ES2016865B3 (es) | 1990-12-01 |
| EP0287901A1 (de) | 1988-10-26 |
| IE60734B1 (en) | 1994-08-10 |
| AU608821B2 (en) | 1991-04-18 |
| ATE55108T1 (de) | 1990-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA882391B (en) | Controlling the growth of tumor tissue with chalcone derivatives | |
| ES2059420T3 (es) | Metodo de tratamiento de esclerosis multiples con derivados chalcona. | |
| CA2098849A1 (en) | Control of gene expression by ionizing radiation | |
| EP0348353A3 (en) | The use of physiologically active substances for the manufacture of drugs for cerebral and neuronal diseases | |
| MX9301942A (es) | Derivados de ciclohexan-ilideno novedosos. | |
| FI852626A0 (fi) | Menetelmä ihmisen tuumorinekroositekijän valmistamiseksi ja sitä koodaava DNA | |
| DE3876052D1 (de) | Medizinische verwendung. | |
| AU7947591A (en) | Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages | |
| DK0524781T3 (da) | Terapeutiske amider | |
| DE3877647D1 (de) | Physiologisch wirksame produkte, verfahren zur herstellung und zusammensetzung. | |
| AU2894389A (en) | Novel preparation and method of use thereof | |
| DE3850154D1 (de) | Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression. | |
| IL119491A0 (en) | cDNA or DNA which inhibits collagen-induced platelet aggregation | |
| PH24634A (en) | Chalcone derivatives and composition | |
| ATE243531T1 (de) | Verwendung von magnesium (mg2+) zur erhöhung der gen-verabreichung bei gentherapie | |
| DE3771584D1 (de) | Zusammensetzungen und anwendung von interleukin-2 und/oder interferon-beta und des tumor-necrosis-faktors fuer eine kombinationstherapie oder zur herstellung von arzneimitteln oder formulierungen. | |
| AU634003B2 (en) | 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants | |
| DE3861494D1 (de) | Pharmazeutische zusammensetzung zur behandlung von tumoren. | |
| DE68916777D1 (de) | Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis. | |
| EP0301449A3 (en) | Enantiomers of propafenone-containing therapeutic agents | |
| GR3034661T3 (en) | Use of Selegiline in vetenary medicine. | |
| AU629423B2 (en) | Treatment of multi-drug resistant tumors with quinolyloxazole-2-ones | |
| AU617277B2 (en) | 2-alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia | |
| DE19780958D2 (de) | Verwendung von Cytokinen und cytotoxischen Substanzen in einem neuen Verfahren zur Tumorbehandlung | |
| IE881077L (en) | Controlling the growth of tumor tissue with chalcone¹derivatives |